$CTXR 4 SEC Filings

Filed On	Filing
23 Sep 2025	Form 4: Mazur Leonard L, Director Disposed of 214,878 Warrant to Purchase Common Stock (Disposition to Issuer) · Granted 214,878 Warrant to Purchase Common Stock
12 Aug 2025	Form 4: Holubiak Myron Z, Director Disposed of 53,717 Warrant to Purchase Common Stock (Disposition to Issuer) · Granted 53,717 Warrant to Purchase Common Stock
12 Nov 2024	Form 4: Webb Carol, Director Granted 125,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Smith Robert Joseph, Director Granted 125,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Bartushak Jaime, Chief Financial Officer Granted 350,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Mazur Leonard L, Director Granted 600,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Czuczman Myron, Chief Medical Officer Granted 300,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Dutia Suren G, Director Granted 125,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Mcgrath Dennis M, Director Granted 125,000 Stock Option (Right to Purchase Common Stock)
12 Nov 2024	Form 4: Holubiak Myron Z, Director Granted 350,000 Stock Option (Right to Purchase Common Stock) · Granted 75,000 Stock Option (Right to Buy)
12 Nov 2024	Form 4: Holuka Eugene Myron, Director Granted 125,000 Stock Option (Right to Purchase Common Stock)
27 Sep 2024	Form 4: Holubiak Myron Z, Director Disposed of 784,314 Warrant to Purchase Common Stock (Disposition to Issuer) · Granted 784,314 Warrant to Purchase Common Stock · Disposed of 558,597 Warrant to Purchase Common Stock (Disposition to Issuer) · 1 more
27 Sep 2024	Form 4: Mazur Leonard L, Director Disposed of 3,137,255 Warrant to Purchase Common Stock (Disposition to Issuer) · Granted 3,137,255 Warrant to Purchase Common Stock · Disposed of 2,234,700 Warrant to Purchase Common Stock (Disposition to Issuer) · 1 more
30 Aug 2024	Form 4: Holuka Eugene Myron, Director Received 2,415 shares by exercise or conversion ($36.2) · Gave up 48 shares to cover exercise price or tax ($36)
30 Aug 2024	Form 4: Webb Carol, Director Received 12,071 shares by exercise or conversion ($181) · Gave up 236 shares to cover exercise price or tax ($181)
14 Aug 2024	Form 4: Citius Pharmaceuticals, Inc., 10% owner · Citius Oncology Inc Holds 65,627,262 shares of Common Stock
05 Apr 2024	Form 4: Mazur Leonard L, Director Disposed of 1,165,048 Warrant to Purchase Common Stock (Disposition to Issuer) · Granted 1,165,048 Warrant to Purchase Common Stock
05 Apr 2024	Form 4: Holubiak Myron Z, Director Disposed of 129,450 Warrant to Purchase Common Stock (Disposition to Issuer) · Granted 129,450 Warrant to Purchase Common Stock
18 Mar 2024	Form 4: Smith Robert Joseph, Director Granted 75,000 Stock Option (Right to Purchase Common Stock)
12 Oct 2023	Form 4: Webb Carol, Director Granted 75,000 Options to Purchase Common Stock

Comments